$CIRX
CirTran Corp Stock $cirx

$cirx Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224015391 Filed on April 19, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$390.5K	$177.7K	$1.616M
YoY Change	-14.83%	651.46%	-6.0%
Cost Of Revenue	$168.6K	$230.5K	$1.121M
YoY Change	-37.57%	-7.79%	60.96%
Gross Profit	$221.9K	-$52.74K	$495.0K
YoY Change	17.73%	-76.69%	-51.61%
Gross Profit Margin	56.83%	-29.68%	30.63%
Selling, General & Admin	$190.5K	-$284.5K	$509.9K
YoY Change	26.6%	-1840.94%	-49.21%
% of Gross Profit	85.86%		103.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$1.250K	$4.510K
YoY Change		22.55%	16.21%
% of Gross Profit			0.91%
Operating Expenses	$316.2K	-$284.5K	$509.9K
YoY Change	9.94%	-1840.94%	-67.0%
Operating Profit	-$94.29K	$231.7K	-$14.91K
YoY Change	-4.87%	-195.51%	-97.15%
Interest Expense		-$479.2K	-$1.061M
YoY Change		125.43%	-249.56%
% of Operating Profit		-206.8%
Other Income/Expense, Net	-$263.6K	$0.00	$1.120K
YoY Change	149.56%		-100.14%
Pretax Income	-$396.1K	$262.6K	-$551.7K
YoY Change	93.48%	-157.69%	-61.98%
Income Tax		-$8.530K	-$8.530K
% Of Pretax Income		-3.25%
Net Earnings	-$396.1K	$21.22M	$20.29M
YoY Change	63.02%	-3994.83%	-1450.67%
Net Earnings / Revenue	-101.44%	11938.7%	1255.35%
Basic Earnings Per Share	-$0.08		$4.10
Diluted Earnings Per Share	-$0.08	$4.29	$4.10
COMMON SHARES
Basic Shares Outstanding	4.945M shares	4.945M shares	4.945M shares
Diluted Shares Outstanding	4.945M shares		4.945M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets	$411.7K	$692.5K	$692.5K
YoY Change	1.94%	110.82%	-11.96%
Inventory	$802.3K	$815.6K	$815.6K
Prepaid Expenses
Receivables	$112.2K	$21.54K	$21.54K
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$1.968M	$1.530M	$1.530M
YoY Change	28.09%	-9.14%	-9.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.48K	$18.93K	$18.93K
YoY Change	-23.5%	26.05%	26.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$300.0K	$300.0K
YoY Change		0.0%	0.0%
Other Assets
YoY Change
Total Long-Term Assets	$316.5K	$318.9K	$318.9K
YoY Change	-1.57%	1.24%	1.24%
TOTAL ASSETS
Total Short-Term Assets	$1.968M	$1.530M	$1.530M
Total Long-Term Assets	$316.5K	$318.9K	$318.9K
Total Assets	$2.284M	$1.849M	$1.849M
YoY Change	22.96%	-7.5%	-7.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$657.6K	$1.213M	$1.213M
YoY Change	-96.91%	-47.82%	-94.36%
Accrued Expenses	$3.234M	$12.86M	$12.86M
YoY Change	45.75%	518.48%	19.79%
Deferred Revenue
YoY Change
Short-Term Debt		$2.322M	$2.322M
YoY Change		-21.73%	-21.73%
Long-Term Debt Due		$593.4K	$593.4K
YoY Change		0.0%	0.0%
Total Short-Term Liabilities	$22.16M	$20.86M	$20.86M
YoY Change	-47.16%	-49.6%	-49.6%
LONG-TERM LIABILITIES
Long-Term Debt		$2.713M	$2.713M
YoY Change		3.36%	3.36%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$2.713M	$2.713M
YoY Change		3.36%	3.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.16M	$20.86M	$20.86M
Total Long-Term Liabilities		$2.713M	$2.713M
Total Liabilities	$24.98M	$23.63M	$23.63M
YoY Change	-44.06%	-46.38%	-46.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$59.93M	-$59.02M
YoY Change	-25.11%	-25.58%
Common Stock	$37.24M	$37.24M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$22.69M	-$21.78M	-$21.78M
YoY Change
Total Liabilities & Shareholders Equity	$2.284M	$1.849M	$1.849M
YoY Change	22.96%	-7.5%	-7.5%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$396.1K	$21.22M	$20.29M
YoY Change	63.02%	-3994.83%	-1450.67%
Depreciation, Depletion And Amortization		$1.250K	$4.510K
YoY Change		22.55%	16.21%
Cash From Operating Activities		-$105.6K	-$72.61K
YoY Change		1109.85%	-145.58%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$8.410K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00	-$8.410K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		82.21K	62.94K
YoY Change		-697.89%	-142.91%
NET CHANGE
Cash From Operating Activities		-105.6K	-72.61K
Cash From Investing Activities		0.000	-8.410K
Cash From Financing Activities		82.21K	62.94K
Net Change In Cash		-23.41K	-18.08K
YoY Change		4.14%	-243.39%
FREE CASH FLOW
Cash From Operating Activities		-$105.6K	-$72.61K
Capital Expenditures		$0.00	$8.410K
Free Cash Flow		-$105.6K	-$81.02K
YoY Change		1109.85%	-150.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q4	us-gaap	Cash Cash		usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q4	CIRX	Liabilities For Product Returns And Credits Current LiabilitiesForProductReturnsAndCreditsCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	CIRX	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022	CIRX	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2022	CIRX	Increase Decrease In Product Return And Credits IncreaseDecreaseInProductReturnAndCredits		usd
CY2023	CIRX	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q4	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	CIRX	Tax Reconciliation Not Required TaxReconciliationNotRequired		usd
CY2022	CIRX	Tax Reconciliation Not Required TaxReconciliationNotRequired		usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Cash DisposalGroupIncludingDiscontinuedOperationCash		usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Cash DisposalGroupIncludingDiscontinuedOperationCash		usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation		usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation		usd
CY2023Q4	CIRX	Related Party Payable Liabilities Of Disposal Group Including Discontinued Operation RelatedPartyPayableLiabilitiesOfDisposalGroupIncludingDiscontinuedOperation		usd
CY2022	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax		usd
CY2022	CIRX	Disposal Group Including Discontinued Operation Gains Losses On Forgiveness Of Debt DisposalGroupIncludingDiscontinuedOperationGainsLossesOnForgivenessOfDebt		usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Security12g Title Security12gTitle	Common Stock, Par Value $0.001
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	136527	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4945417	shares
CY2023	dei	Auditor Firm AuditorFirmId	5525
CY2023	dei	Auditor Name AuditorName	Fruci & Associates II, PLLC
CY2023	dei	Auditor Location AuditorLocation	Spokane, Washington
CY2022Q4	us-gaap	Cash Cash	18081	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	815612	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	816014	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	39438	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21536	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	62873	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	441095	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	328468	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1529637	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1683509	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	300000	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	300000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18925	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15018	usd
CY2023Q4	us-gaap	Assets Assets	1848562	usd
CY2022Q4	us-gaap	Assets Assets	1998527	usd
CY2023Q4	CIRX	Liabilities For Product Returns And Credits Current LiabilitiesForProductReturnsAndCreditsCurrent	8701	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2889389	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2079252	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5067213	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4794836	usd
CY2023	CIRX	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	194709	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	5758603	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	5214530	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	264284	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	264284	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1296937	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1004837	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	4511075	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	25342601	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20858731	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	41390374	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	55946	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	50888	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	634636	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	656000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	2077934	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	1968310	usd
CY2023Q4	us-gaap	Liabilities Liabilities	23627247	usd
CY2022Q4	us-gaap	Liabilities Liabilities	44065572	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4945417	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4945417	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4945417	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4945417	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4945	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	4945	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	37233561	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	37233561	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-59017191	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-79305551	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-21778685	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-42067045	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1848562	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1998527	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1616148	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1719358	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	609651	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	696548	usd
CY2023	us-gaap	Gross Profit GrossProfit	1006497	usd
CY2022	us-gaap	Gross Profit GrossProfit	1022810	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	511519	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	541090	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	509895	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1004003	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1021414	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1545093	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-14917	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-522283	usd
CY2023	us-gaap	Interest Expense InterestExpense	768899	usd
CY2022	us-gaap	Interest Expense InterestExpense	709414	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	328384	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-66040	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-536782	usd
CY2023	CIRX	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterests	-551699	usd
CY2022	CIRX	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interests IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterests	-1297737	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	20831526	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-153466	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20279827	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1451203	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8533	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	50888	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	20288360	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1502091	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.11
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.11
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.27
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.27
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	4.21
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	4.21
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.03
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.03
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.10
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.10
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4945417	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4945417	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4945417	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4945417	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-40564954	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1502091	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-42067045	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-42067045	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	20288360	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	20288360	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-21778685	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-21778685	usd
CY2023	us-gaap	Profit Loss ProfitLoss	20288360	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1502091	usd
CY2023	CIRX	Loss From Discontinued Operations LossFromDiscontinuedOperations	-20831526	usd
CY2022	CIRX	Loss From Discontinued Operations LossFromDiscontinuedOperations	153466	usd
CY2023	us-gaap	Depreciation Depreciation	4507	usd
CY2022	us-gaap	Depreciation Depreciation	3881	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-292100	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-66040	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	109624	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	91689	usd
CY2023	CIRX	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	194709	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	328384	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	22291	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-402	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	278053	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-13457	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	28801	usd
CY2023	CIRX	Increase Decrease In Deposits On Inventory Related Party IncreaseDecreaseInDepositsOnInventoryRelatedParty	-193222	usd
CY2022	CIRX	Increase Decrease In Deposits On Inventory Related Party IncreaseDecreaseInDepositsOnInventoryRelatedParty	330591	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-41337	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-149371	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	112627	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	60648	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1188715	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	399949	usd
CY2023	CIRX	Increase Decrease In Product Return And Credits IncreaseDecreaseInProductReturnAndCredits	8701	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	810136	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	644758	usd
CY2022	CIRX	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	22291	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	272377	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	465133	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	544073	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	334313	usd
CY2023	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	5058	usd
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	50888	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-72607	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	159304	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8414	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8414	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	4182	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	114600	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	8137	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	47478	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	154832	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	62940	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-146695	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-18081	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12609	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18081	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5472	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18081	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_801_eus-gaap--NatureOfOperations_z8P1YDbTnq04" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 — <span id="xdx_827_zO5Fg1UWtVM4">ORGANIZATION AND NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 1987, CirTran Corporation was incorporated in Nevada under the name Vermillion Ventures, Inc., for the purpose of acquiring other operating corporate entities. We were largely inactive until July 1, 2000, when our wholly owned subsidiary, CirTran Corporation (Utah), acquired substantially all the assets and certain liabilities of Circuit Technology, Inc., founded by our president, Iehab Hawatmeh.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We, together with our majority-owned subsidiaries, manufacture, distribute, and sell condoms, electronic tobacco products, cigars, energy drinks, water beverages, and related merchandise, all using the HUSTLER® brand name. Since entering our 2019 five-year manufacturing and distribution agreement with an unrelated party, our efforts have been devoted to phase one of our development of all HUSTLER®-branded products, which led us to generating revenue during 2020 for the first time in several years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	CIRX	Use Of Estimate UseOfEstimate	<p id="xdx_847_ecustom--UseOfEstimate_zYrAM3X0yHJi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zxj42esoxbqc">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zpLRf7i7pw58" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_zHhImlOp5bOg">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing the financial statements in accordance with US GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zhQxFV40gp69" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_zCHAIIOAvhP2">Concentrations of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may exceed the Federal Deposit Insurance Corporation insurable limit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	43023	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	28343	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	815612	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	816014	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023	CIRX	Percentage Of Royalty Gross Sales PercentageOfRoyaltyGrossSales	0.08	pure
CY2023	us-gaap	Royalty Expense RoyaltyExpense	350000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	39438	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	300000	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	300000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	772589	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	787671	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	1296937	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	1004837	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	216834000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	106623280	shares
CY2023Q4	CIRX	Working Capital Deficiency WorkingCapitalDeficiency	19329094	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-543166	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-59017191	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30884	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22470	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11959	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7452	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18925	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15018	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4508	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3881	usd
CY2023	CIRX	Increase Decrease In Deposits On Inventory Related Parties IncreaseDecreaseInDepositsOnInventoryRelatedParties	193222	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	37228	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	548811	usd
CY2023Q4	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	1092915	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1759246	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1530441	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2889389	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2079252	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	45000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	45000	usd
CY2023Q4	CIRX	Advance Customer Deposits AdvanceCustomerDeposits	1735109	usd
CY2022Q4	CIRX	Advance Customer Deposits AdvanceCustomerDeposits	1437361	usd
CY2023Q4	CIRX	Accrued Director Fees Current AccruedDirectorFeesCurrent	135000	usd
CY2022Q4	CIRX	Accrued Director Fees Current AccruedDirectorFeesCurrent	135000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	121858	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	121858	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	2148	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	2148	usd
CY2023Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	438822	usd
CY2022Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	500322	usd
CY2023Q4	CIRX	Accrued Administrative Payroll Current AccruedAdministrativePayrollCurrent	4369385	usd
CY2022Q4	CIRX	Accrued Administrative Payroll Current AccruedAdministrativePayrollCurrent	4035508	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5067213	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4794836	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2000	shares
CY2023Q4	CIRX	Notes Payablet To Former Service Provider NotesPayabletToFormerServiceProvider	90000	usd
CY2022Q4	CIRX	Notes Payablet To Former Service Provider NotesPayabletToFormerServiceProvider	90000	usd
CY2023Q4	CIRX	Note Payable For Settlement Of Debt NotePayableForSettlementOfDebt	500000	usd
CY2022Q4	CIRX	Note Payable For Settlement Of Debt NotePayableForSettlementOfDebt	500000	usd
CY2023Q4	CIRX	Small Business Administration Loan SmallBusinessAdministrationLoan	134636	usd
CY2022Q4	CIRX	Small Business Administration Loan SmallBusinessAdministrationLoan	143000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	724636	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	733000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2665528	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2665528	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	323310	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	432934	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	2342218	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	2232594	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	264284	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	264284	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	2077934	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	1968310	usd
CY2023	us-gaap	Debt Instrument Convertible Stock Price Trigger DebtInstrumentConvertibleStockPriceTrigger	100
CY2023	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	integer
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2665528	usd
CY2023	us-gaap	Debt Instrument Convertible Terms Of Conversion Feature DebtInstrumentConvertibleTermsOfConversionFeature	convertible at the holder’s option into common stock of the company at the lesser of $100 (notes one through four) or $0.10 (note five) or the lowest closing bid price in the prior 20 trading days
CY2023	us-gaap	Debt Instrument Convertible Stock Price Trigger DebtInstrumentConvertibleStockPriceTrigger	100
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-292100	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-66040	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1296937	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1004837	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3800000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	21400000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	50888	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8533	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1177300	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5461800	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1177300	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5461800	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4260600	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-315400	usd
CY2023	CIRX	Income Tax Reconciliation Change In Payroll Accruals IncomeTaxReconciliationChangeInPayrollAccruals	57200	usd
CY2022	CIRX	Income Tax Reconciliation Change In Payroll Accruals IncomeTaxReconciliationChangeInPayrollAccruals	74200	usd
CY2023	CIRX	Income Tax Reconciliation Allowance For Doubtful Accounts IncomeTaxReconciliationAllowanceForDoubtfulAccounts	-8300	usd
CY2022	CIRX	Income Tax Reconciliation Allowance For Doubtful Accounts IncomeTaxReconciliationAllowanceForDoubtfulAccounts	8300	usd
CY2023	CIRX	Income Tax Reconciliation Nondeductible Expense Amortization Of Debt Discount IncomeTaxReconciliationNondeductibleExpenseAmortizationOfDebtDiscount	23000	usd
CY2022	CIRX	Income Tax Reconciliation Nondeductible Expense Amortization Of Debt Discount IncomeTaxReconciliationNondeductibleExpenseAmortizationOfDebtDiscount	19255	usd
CY2023	CIRX	Income Tax Reconciliation Change In Derivative Liability IncomeTaxReconciliationChangeInDerivativeLiability	61300	usd
CY2022	CIRX	Income Tax Reconciliation Change In Derivative Liability IncomeTaxReconciliationChangeInDerivativeLiability	13868	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-4393800	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	199777	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	40000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	40000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.03
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.03
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y8M4D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y8M4D
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	40000	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.03
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y11M8D
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	40000	shares
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable DisposalGroupIncludingDiscontinuedOperationAccountsPayable	283818	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable DisposalGroupIncludingDiscontinuedOperationAccountsPayable	18338848	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities	58184	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities	589380	usd
CY2023Q4	CIRX	Disposal Group Including Discontinued Operation Interest Payable DisposalGroupIncludingDiscontinuedOperationInterestPayable	1636624	usd
CY2022Q4	CIRX	Disposal Group Including Discontinued Operation Interest Payable DisposalGroupIncludingDiscontinuedOperationInterestPayable	1483157	usd
CY2023Q4	CIRX	Disposal Group Including Discontinued Operation Accrued Payroll And Compensation Expense DisposalGroupIncludingDiscontinuedOperationAccruedPayrollAndCompensationExpense	122864	usd
CY2022Q4	CIRX	Disposal Group Including Discontinued Operation Accrued Payroll And Compensation Expense DisposalGroupIncludingDiscontinuedOperationAccruedPayrollAndCompensationExpense	131108	usd
CY2023Q4	CIRX	Current Maturities Of Longterm Debt Of Disposal Group Including Discontinued Operation CurrentMaturitiesOfLongtermDebtOfDisposalGroupIncludingDiscontinuedOperation	239085	usd
CY2022Q4	CIRX	Current Maturities Of Longterm Debt Of Disposal Group Including Discontinued Operation CurrentMaturitiesOfLongtermDebtOfDisposalGroupIncludingDiscontinuedOperation	239085	usd
CY2022Q4	CIRX	Related Party Payable Liabilities Of Disposal Group Including Discontinued Operation RelatedPartyPayableLiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	1776250	usd
CY2023Q4	CIRX	Shortterm Advances Payable Of Disposal Group Including Discontinued Operation ShorttermAdvancesPayableOfDisposalGroupIncludingDiscontinuedOperation	2170500	usd
CY2022Q4	CIRX	Shortterm Advances Payable Of Disposal Group Including Discontinued Operation ShorttermAdvancesPayableOfDisposalGroupIncludingDiscontinuedOperation	2784773	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	4511075	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	25342601	usd
CY2023	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	18878359	usd
CY2023	CIRX	Disposal Group Including Discontinued Operation Gains Losses On Forgiveness Of Debt DisposalGroupIncludingDiscontinuedOperationGainsLossesOnForgivenessOfDebt	2106633	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Interest Expense DisposalGroupIncludingDiscontinuedOperationInterestExpense	153466	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Interest Expense DisposalGroupIncludingDiscontinuedOperationInterestExpense	153466	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	20831526	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-153466	usd

Files In Submission

Name	View Source	Status
0001493152-24-015391-index-headers.html	Edgar Link	pending
0001493152-24-015391-index.html	Edgar Link	pending
0001493152-24-015391.txt	Edgar Link	pending
0001493152-24-015391-xbrl.zip	Edgar Link	pending
cirx-20231231.xsd	Edgar Link	pending
ex31-01.htm	Edgar Link	pending
ex32-01.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
cirx-20231231_cal.xml	Edgar Link	unprocessable
cirx-20231231_lab.xml	Edgar Link	unprocessable
cirx-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cirx-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CIRX
CirTran Corp Stock $cirx

2024 Q2 Form 10-K Financial Statement

#000149315224015391 Filed on April 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CIRX CirTran Corp Stock $cirx

2024 Q2 Form 10-K Financial Statement

#000149315224015391 Filed on April 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CIRX
CirTran Corp Stock $cirx